What Is TZ2?
A dual GIP and GLP-1 receptor agonist studied for incretin-pathway signaling and metabolic regulation.
01Definition
TZ2 is a metabolic research compound. A dual GIP and GLP-1 receptor agonist studied for incretin-pathway signaling and metabolic regulation. It is also known as LY3298176.
Sequence · Synthetic 39-aa dual-incretin agonist
02Research Mechanism
TZ2 is a synthetic 39-amino-acid peptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In research models it is studied for the combined activation of both incretin pathways and downstream effects on insulin secretion, glucose homeostasis, and energy metabolism.
Research framing only · No human-use claims
03Key Facts
| Classification | Metabolic |
| Molecular weight | 4,813.45 g/mol |
| Also known as | LY3298176 |
| Purity spec | ≥99% HPLC |
| Verification | MZ Biolabs · 5-panel |
| Use | Research Use Only |
04FAQ
What is TZ2?
TZ2 is a metabolic research compound. A dual GIP and GLP-1 receptor agonist studied for incretin-pathway signaling and metabolic regulation. It is also known as LY3298176. It is supplied strictly for laboratory research use.
What class of compound is TZ2?
TZ2 is categorized as Metabolic and is studied alongside related compounds in that research area.
What is the molecular weight of TZ2?
TZ2 has a molecular weight of 4,813.45 g/mol.
How is TZ2 tested?
Every Ethos Bio lot of TZ2 is analyzed by an independent third-party laboratory (MZ Biolabs, Arizona) on a five-point panel — HPLC purity, mass-spec identity, endotoxin, heavy metals, and sterility — with a batch-specific Certificate of Analysis.